Immersive Virtual Reality for Dual-task Training in Older Adults With Mild Cognitive Impairment: A Randomized Controlled Trial
NCT05730790, Not applicable, Unknown, Tan Tock Seng Hospital
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Immersive Virtual Reality for Dual-task Training in Older Adults With Mild Cognitive Impairment: A Randomized Controlled Trial | ClinicalTrials.gov |
| NCT number | NCT05730790 | ClinicalTrials.gov |
| Status | Unknown | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 54 participants, estimated | ClinicalTrials.gov |
| Lead sponsor | Tan Tock Seng Hospital | ClinicalTrials.gov |
| Conditions | Mild Cognitive Impairment | ClinicalTrials.gov |
| Interventions | Cognitive-motor dual task training (DTT), Cognitive single task training (CSTT), Motor single task training (MSTT) | ClinicalTrials.gov |
| First posted | 2023-02-16 | ClinicalTrials.gov |
| Last updated | 2023-02-16 | ClinicalTrials.gov |
Registered outcomes 9
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Change in dual-task gait cost measured using Optogait | Baseline, post-intervention after session 14 (week 7), 6 month | Gait parameters collected include step length, single support time, double support time, step time, stride length, speed and cadence. Gait parameters are collected under both single and dual-task (serial seven subtraction and animal naming) conditions. Dual-task cost calculated as 100\*(single task parameter - dual-task parameter)/single task parameter | ClinicalTrials.gov |
| Primary | Change in dual-task cognitive cost measured using corrected response rate of cognitive tasks | Baseline, post-intervention after session 14 (week 7), 6 month | Cognitive tasks include 30 seconds serial seven subtraction and animal naming, under both single and dual-task conditions (while walking) | ClinicalTrials.gov |
| Secondary | Change in number of falls measured using a falls diary | Baseline, 6 month | Number of falls in the past 12 months | ClinicalTrials.gov |
| Secondary | Change in balance parameters and falls risk measured using Berg Balance Scale (BBS) | Baseline, post-intervention after session 14 (week 7), 6 month | BBS is a 14-item tool which objectively assesses static balance and falls risk. | ClinicalTrials.gov |
| Secondary | Change in falls risk measured using Timed Up and Go test (TUG) | Baseline, post-intervention after session 14 (week 7), 6 month | TUG is a evaluative tool which assesses functional mobility and falls risk | ClinicalTrials.gov |
| Secondary | Change in falls concerns scored using the Falls Efficacy Scale International (FES-I) | Baseline, post-intervention after session 14 (week 7), 6 month | FES-I is a 16-item questionnaire used to measure the level of concern about falling during social and physical activities. | ClinicalTrials.gov |
| Secondary | Change in executive function measured using Chinese Frontal Assessment Battery | Baseline, 6 month | CFAB is brief tool used to assess frontal dysfunction via a series of neuropsychological tasks. A higher score indicates better performance with a total maximum of 18. | ClinicalTrials.gov |
| Secondary | Change in executive function scored using the Stroop color-word test - Victoria version (VST) | Baseline, 6 month | VST assess executive functioning using three conditions that consist in naming color of dots, of neutral words, and of color words printed in incongruent colors. | ClinicalTrials.gov |
| Secondary | Change in sustained and divided attention assessed using Color Trails Test 1 and 2 | Baseline, 6 month | Color Trails Test is the language free version of Trails Making Test, developed for cross-cultural assessment of sustained and divided attention in adults | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 10
The papers the trial lists on ClinicalTrials.gov.
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 2
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| Category Fluency | Primary outcome | ConductCognition |
| Stroop Color-Word Test | Secondary outcome | ConductCognition |
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)